Other languages Biotron Limited

Equities

BIT

AU000000BIT4

Delayed Australian S.E. Other stock markets 08:12:57 2024-07-11 pm EDT			5-day change	1st Jan Change
0.032 ^AUD	-3.03%		-13.51%	-67.01%

Jun. 19	Biotron's HIV Therapy Meets Primary Endpoints in Phase Two Trial; Shares Rally 15%	MT
Apr. 05	Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25%	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biotron's HIV Therapy Meets Primary Endpoints in Phase Two Trial; Shares Rally 15%	Jun. 18
Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25%	Apr. 04
Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 26
Biotron Secures Nearly AU$2 Million R&D Tax Rebate in Fiscal 2023	Feb. 08
Biotron Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-25
Biotron Begins Phase Two COVID-19 Trial for Antiviral Medication	23-05-04
Biotron Completes Phase 2 HIV-1 Trial for Antiviral Drug	23-03-09
Biotron Limited Announces Completion of Phase 2 HIV-1 Clinical Trials	23-03-08
Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-16
Biotron Receives $958,000 R&D Tax Rebate for Drug Development Programs	22-11-18
Biotron Raising $2.7 Million for Clinical Trials, Drug Development; Shares Fall 20%	22-10-27
Biotron Completes Enrollment for Phase 2 HIV Trial; Shares Jump 7%	22-10-04
Biotron Starts Human Trials of COVID-19 Antiviral Drug; Shares Jump 13%	22-09-13
Biotron Completes Enrollment for Phase 2 HIV Trial in Thailand	22-08-23
Biotron Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-19
Biotron Limited Auditor Raises 'Going Concern' Doubt	22-08-18
Nanomix Corporation Announces Distribution Agreement for the eLab System with Biotron Ltd. in Israel	22-07-21
Biotron Secures US FDA Guidance for COVID-19 Antiviral Drug	22-05-30
Biotron Limited Receives Positive U.S. Food and Drug Administrations Guidance for COVID-19 Clinical Program	22-05-29
Biotron's Drug Candidate Effective Against SARS-CoV-2 Infected Mice	22-05-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Biotron Limited

Equities

BIT

AU000000BIT4

Other languages

Filters